The concept that blocking the farnesylation of progerin might help ameliorate disease pathology seen in HGPS cells was proposed in 2003, shortly after the discovery of the gene involved in causing HGPS. The gene discussed is LMNA; the disease is Hutchinson-Gilford progeria syndrome.